Cogent Biosciences, Inc.
COGT
$37.93
$0.621.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 233.11% | 252.67% | 213.77% | 16.50% | -34.52% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 74.86% | 58.18% | 2.08% | 5.74% | 6.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 228.49% | 247.12% | 207.06% | 16.31% | -33.78% |
|
|
|||||
| Total Current Assets | 228.49% | 247.12% | 207.06% | 16.31% | -33.78% |
| Net Property, Plant & Equipment | 9.72% | -12.30% | -11.40% | -13.52% | -12.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -51.56% | -51.54% | -23.55% | -0.78% | 0.00% |
| Total Assets | 203.67% | 218.19% | 185.94% | 10.92% | -36.08% |
|
|
|||||
| Total Accounts Payable | -54.96% | -2.90% | -20.89% | 6.43% | 85.24% |
| Total Accrued Expenses | 26.08% | 24.01% | 10.53% | 19.54% | 32.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.19% | -14.15% | -1.15% | 12.24% | 12.41% |
| Total Finance Division Other Current Liabilities | 3.53% | 281.40% | 1,708.31% | 319.93% | 405.16% |
| Total Other Current Liabilities | 3.53% | 281.40% | 1,708.31% | 319.93% | 405.16% |
| Total Current Liabilities | 1.50% | 17.57% | 14.80% | 17.34% | 46.04% |
|
|
|||||
| Total Current Liabilities | 1.50% | 17.57% | 14.80% | 17.34% | 46.04% |
| Long-Term Debt | 408.45% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 28.33% | -8.93% | -9.73% | -10.46% | -9.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -96.18% | 1,140.00% | -- | -- | -- |
| Total Liabilities | 152.26% | 355.71% | 320.65% | 78.02% | 111.21% |
|
|
|||||
| Common Stock & APIC | 75.89% | 75.52% | 72.69% | 28.71% | 7.33% |
| Retained Earnings | -37.53% | -38.04% | -38.27% | -37.19% | -39.40% |
| Treasury Stock & Other | -6,023.08% | -353.05% | -20.58% | -76.79% | 106.77% |
| Total Common Equity | 892.41% | 389.89% | 275.45% | -4.66% | -81.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -40.00% | -40.13% | -19.17% | -2.43% | -5.44% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -40.00% | -40.13% | -19.17% | -2.43% | -5.44% |
|
|
|||||
| Total Common Equity | 892.41% | 389.89% | 275.45% | -4.66% | -81.81% |
| Total Preferred Equity | -40.00% | -40.13% | -19.17% | -2.43% | -5.44% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 243.40% | 177.49% | 148.31% | -3.88% | -58.46% |
|
|
|||||